New Respiratory Therapy’s Clinical Program Getting European Patent Protection
COPD, Idiopathic Pulmonary Fibrosis, News, Pulmonary Hypertension
Bellerophon Therapeutics, Inc., a clinical-stage biotherapeutics company specializing in the development of drugs and devices for cardiopulmonary conditions, recently announced that the European Patent Office has issued a Notice of Intention ... Read more